Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12688/f1000research.10760.1 http://scihub22266oqcxt.onion/10.12688/f1000research.10760.1 C5461897!5461897!28620463     free     free     free       F1000Res 2017 ; 6 (ä): ä Nephropedia Template TP {{tp|p=28620463|t=2017. Recent advances in the management of Wilms tumor |pdf=|usr=}}{{28620463}} gab.com Text Recent advances in the management of Wilms tumor JO: F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=28620463 #FOAvip The objective of this article is to present an overview of recent trends in the management of Wilms? tumor. With improved survival rates in the past few decades, critical long-term adverse therapy effects (such as renal insufficiency, secondary malignancies, and heart failure) and prevention measures (i.e. nephron-sparing surgery and minimizing the use of radiotherapy) have gained worldwide attention. Specific disease biomarkers that could help stratify high-risk from low-risk patients, and therefore fine-tune management, are in great demand. Ultimately, we aim to enhance clinical outcomes and maintain or improve current survival rates while avoiding undesirable treatment side effects and minimizing the exposure and intensity of chemotherapy and radiotherapy. Twit Text FOAVip Recent advances in the management of Wilms tumor ????F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=28620463 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28620463 #FOAvip English Wikipedia <ref>{{Cite pmid|28620463}}</ref> Recent advances in the management of Wilms tumor #MMPMID28620463 Lopes RI; Lorenzo A F1000Res 2017[]; 6 (ä): ä PMID28620463show ga The objective of this article is to present an overview of recent trends in the management of Wilms? tumor. With improved survival rates in the past few decades, critical long-term adverse therapy effects (such as renal insufficiency, secondary malignancies, and heart failure) and prevention measures (i.e. nephron-sparing surgery and minimizing the use of radiotherapy) have gained worldwide attention. Specific disease biomarkers that could help stratify high-risk from low-risk patients, and therefore fine-tune management, are in great demand. Ultimately, we aim to enhance clinical outcomes and maintain or improve current survival rates while avoiding undesirable treatment side effects and minimizing the exposure and intensity of chemotherapy and radiotherapy. äRecent advances in the management of Wilms tumor (epmc).pdf DeepDyve Pubget Overpricing